BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 29981911)

  • 1. Giant Pediatric Rhabdoid Meningioma Associated with a Germline BAP1 Pathogenic Variation: A Rare Clinical Case.
    Ravanpay AC; Barkley A; White-Dzuro GA; Cimino PJ; Gonzalez-Cuyar LF; Lockwood C; Halasz LM; Hisama FM; Ferreira M
    World Neurosurg; 2018 Nov; 119():402-415. PubMed ID: 29981911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.
    Shankar GM; Abedalthagafi M; Vaubel RA; Merrill PH; Nayyar N; Gill CM; Brewster R; Bi WL; Agarwalla PK; Thorner AR; Reardon DA; Al-Mefty O; Wen PY; Alexander BM; van Hummelen P; Batchelor TT; Ligon KL; Ligon AH; Meyerson M; Dunn IF; Beroukhim R; Louis DN; Perry A; Carter SL; Giannini C; Curry WT; Cahill DP; Barker FG; Brastianos PK; Santagata S
    Neuro Oncol; 2017 Apr; 19(4):535-545. PubMed ID: 28170043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline BAP1 Mutation in a Family With Multi-Generational Meningioma With Rhabdoid Features: A Case Series and Literature Review.
    Prasad RN; Gardner UG; Yaney A; Prevedello DM; Koboldt DC; Thomas DL; Mardis ER; Palmer JD
    Front Oncol; 2021; 11():721712. PubMed ID: 34504799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAP1 mutations in high-grade meningioma: implications for patient care.
    Shankar GM; Santagata S
    Neuro Oncol; 2017 Oct; 19(11):1447-1456. PubMed ID: 28482042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
    Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations.
    Hu ZI; Miettinen M; Quezado M; Lebensohn AP; Aldape K; Agra M; Wagner C; Mallory Y; Hassan R; Ghafoor A
    J Thorac Oncol; 2022 Mar; 17(3):461-466. PubMed ID: 34628055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
    Abdel-Rahman MH; Pilarski R; Cebulla CM; Massengill JB; Christopher BN; Boru G; Hovland P; Davidorf FH
    J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational Analysis of Recurrent Meningioma Progressing From Atypical to Rhabdoid Subtype.
    Bujko M; Machnicki MM; Grecka E; Rusetska N; Matyja E; Kober P; Mandat T; Rydzanicz M; Płoski R; Krajewski R; Bonicki W; Stokłosa T; Siedlecki JA
    World Neurosurg; 2017 Jan; 97():754.e1-754.e6. PubMed ID: 27756662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based analysis of germline BAP1 mutations in melanoma.
    O'Shea SJ; Robles-Espinoza CD; McLellan L; Harrigan J; Jacq X; Hewinson J; Iyer V; Merchant W; Elliott F; Harland M; Bishop DT; Newton-Bishop JA; Adams DJ
    Hum Mol Genet; 2017 Feb; 26(4):717-728. PubMed ID: 28062663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.
    Haugh AM; Njauw CN; Bubley JA; Verzì AE; Zhang B; Kudalkar E; VandenBoom T; Walton K; Swick BL; Kumar R; Rana HQ; Cochrane S; McCormick SR; Shea CR; Tsao H; Gerami P
    JAMA Dermatol; 2017 Oct; 153(10):999-1006. PubMed ID: 28793149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
    Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
    J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
    Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK
    J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAP1 Tumor Predisposition Syndrome Presenting as a Recurrent Ovarian Sex Cord-Stromal Tumor.
    Albright BB; Wignall E; Bentley RC; Havrilesky LJ; Previs RA; Strickland KC
    Int J Gynecol Pathol; 2023 Jan; 42(1):83-88. PubMed ID: 35348477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
    Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH
    Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
    Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
    Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP1-deficient meningioma presenting with trabecular architecture and cytokeratin expression: a report of two cases and review of the literature.
    Landry AP; Wang JZ; Nassiri F; Patil V; Gao A; Zadeh G
    J Clin Pathol; 2023 May; 76(5):315-319. PubMed ID: 34907091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.
    Wadt KA; Aoude LG; Johansson P; Solinas A; Pritchard A; Crainic O; Andersen MT; Kiilgaard JF; Heegaard S; Sunde L; Federspiel B; Madore J; Thompson JF; McCarthy SW; Goodwin A; Tsao H; Jönsson G; Busam K; Gupta R; Trent JM; Gerdes AM; Brown KM; Scolyer RA; Hayward NK
    Clin Genet; 2015 Sep; 88(3):267-72. PubMed ID: 25225168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.